The role of inhibitor of DNA-binding (Id1) in hyperproliferation of keratinocytes: The pathological basis for middle ear cholesteatoma from chronic otitis media

Cell Proliferation

Volumn 43, Issue 5, 2010, Pages 457-463

  Hamajima, Y ^a,b   Komori, M ^a   Preciado, D A ^a   Choo, D I ^c   Moribe, K ^b   Murakami, S ^b   Ondrey, F G ^a   Lin, J ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b NAGOYA CITY UNIVERSITY   (Japan)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYTOKERATIN 10; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INHIBITOR OF DIFFERENTIATION 1; KI 67 ANTIGEN; MUTANT PROTEIN; PYRROLIDINE DITHIOCARBAMATE; TRANSCRIPTION FACTOR RELA; CYCLIN DEPENDENT KINASE INHIBITOR 2A; ID1 PROTEIN, HUMAN;

ARTICLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CHOLESTEATOMA; CHRONIC OTITIS MEDIA; DNA BINDING; ENZYME INDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KERATINOCYTE; PATHOGENESIS; CELL LINE; CYTOLOGY; DOWN REGULATION; GENETICS; METABOLISM; OTITIS MEDIA; UPREGULATION;

CELL LINE; CELL PROLIFERATION; CHOLESTEATOMA, MIDDLE EAR; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P16; DOWN-REGULATION; HUMANS; INHIBITOR OF DIFFERENTIATION PROTEIN 1; KERATIN-10; KERATINOCYTES; KI-67 ANTIGEN; NF-KAPPA B; OTITIS MEDIA; TRANSFECTION; UP-REGULATION;

EID: 77956249338     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/j.1365-2184.2010.00695.x     Document Type: Article

References (35)

1. Lin J, Tsuboi Y, Pan W, Giebink SG, Adams GL, Kim Y (2002) Analysis by cDNA microarrays of altered gene expression in middle ears of rats following penumococcal infection. Int. J. Pediatr. Otorhinolaryngol. 65, 203 211.
2. Zhang QA, Hamajima Y, Zhang Q, Lin J (2008) Identification of Id1 in acquired middle ear cholesteatoma. Arch. Otolaryngol. 134, 306 310.
3. Norton JD, Atherton GT (1998) Coupling of cell growth control and apoptosis functions of Id proteins. Mol. Cell. Biol. 18, 2371 2381.
4. Norton JD, Deed RW, Craggs G, Sablitzky F (1998) Id helix-loop-helix proteins in cell growth and differentiation. Trends Cell Biol. 8, 58 65.
5. Benezra R, Davis RL, Lockshon D, Turner DL, Weintraub H (1990) The protein Id: a negative regulator of helix-loop-helix DNA binding proteins. Cell 61, 49 59.
6. Norton JD (2000) ID helix-loop-helix proteins in cell growth, differentiation and tumorigenesis. J. Cell Sci. 113, 3897 3905.
7. Alani RM, Hasskarl J, Grace M, Hernandez MC, Israel MA, Munger K (1999) Immortalization of primary human keratinocytes by the helix-loop-helix protein, Id-1. Proc. Natl. Acad. Sci. USA 96, 9637 9641.
8. Nickoloff BJ, Chaturvedi V, Bacon P, Qin JZ, Denning MF, Diaz MO (2000) Id-1 delays senescence but does not immortalize keratinocytes. J. Biol. Chem. 275, 27501 27504.
9. Hamajima Y, Toyama K, Zhao Z, Kim Y, Ondrey FG, Lin J (2003) Id1 induces the proliferation of middle ear epithelial cells in rats. In : The Eighth International Symposium on Recent Advances in Otitis Media. Lim D.J., Bluestone C.D., Casselbrant M. (eds). Fort Lauderdale, FL, USA : BC Decker, 274 276.
10. Gamou S, Shimizu N (1987) Change in metabolic turnover is an alternate mechanism increasing cell surface epidermal growth factor receptor levels in tumor cells. J. Biol. Chem. 262, 6708 6713.
11. Ozeki M, Hamajima Y, Feng L, Ondrey FG, Zheng M, Schlentz EP et al. (2007) Id1 induces the proliferation of cochlear sensorineural epithelial cells via the NF-kB/cyclin D1 pathway in vitro. J. Neurosci. Res. 85, 515 524.
12. Lin J, Guan Z, Wang C, Feng L, Zheng Y, Granados E et al. (2010) Id1 regulates the survival of HNSCC via the NF-kB/survivin and PI3K/Akt signaling pathways. Clin Cancer Res. 16, 77 87.
13. Van Antwerp DJ, Martin SJ, Kafri T, Green DR, Verma IM (1996) Suppression of TNF-alpha-induced apoptosis by NF-kappaB. Science 274, 787 789.
14. Gilmore TD, Koedood M, Piffat KA, White DW (1996) Rel/NF-kappaB/IkappaB proteins and cancer. Oncogene 13, 1367 1378.
15. Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA (1992) Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells. J. Exp. Med. 175, 1181 1194.
16. Chun KS, Cha HH, Shin JW, Na HK, Park KK, Chung WY et al. (2004) Nitric oxide induces expression of cyclooxygenase-2 in mouse skin through activation of NF-kappaB. Carcinogenesis 25, 445 454.
17. Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A et al. (1995) Transforming p21ras mutants and c-Ets-2 activate the cyclin D1 promoter through distinguishable regions. J. Biol. Chem. 270, 23589 23597.
18. Fujita T, Nolan GP, Liou HC, Scott ML, Baltimore D (1993) The candidate proto-oncogene bcl-3 encodes a transcriptional coactivator that activates NF-kappa B p50 homodimers. Genes Dev. 7, 1354 1363.
19. Lin J, Tsprun V, Kawano H, Paparella MM, Zhang Z, Andway R et al. (2001) Characterization of mucins in human middle ear and eustachian tube. Am. J. Physiol. Lung Cell. Mol. Physiol. 280, L1157 L1167.
20. Toyama K, Kim Y, Paparella MM, Lin J (2004) Temperature-sensitive SV40 immortalized rat middle ear epithelial cells. Ann. Otol. Rhinol. Laryngol. 113, 967 974.
21. Tsuchiya K, Kim Y, Ondrey FG, Lin J (2005) Characterization of a temperature-sensitive mouse middle ear epithelial cell line. Acta Otolaryngol. 125, 823 829.
22. Shapiro GI, Rollins BJ (1996) p16INK4A as a human tumor suppressor. Biochim. Biophys. Acta 1242, 165 169.
23. Lyden D, Young AZ, Zagzag D, Yan W, Gerald W, O'Reilly R et al. (1999) Id1 and Id3 are required for neurogenesis, angiogenesis and vascularization of tumour xenografts. Nature 401, 670 677.
24. Weinberg RA (1995) The retinoblastoma protein and cell cycle control. Cell 81, 323 330.
25. Sherr CJ (1993) Mammalian G1 cyclins. Cell 73, 1059 1065.
26. Michaels L (1989) Biology of cholesteatoma. Otolaryngol. Clin. North Am. 22, 869 881.
27. Broekaert D, Coucke P, Leperque S, Ramaekers F, Van Muijen G, Boedts D et al. (1992) Immunohistochemical analysis of the cytokeratin expression in middle ear cholesteatoma and related epithelial tissues. Ann. Otol. Rhinol. Laryngol. 101, 931 938.
28. Ergun S, Zheng X, Carlsoo B (1994) Antigen expression of epithelial markers, collagen IV and Ki67 in middle ear cholesteatoma. An immunohistochemical Study. Acta Otolaryngol. 114, 295 302.
29. Roop DR, Krieg TM, Mehrel T, Cheng CK, Yuspa SH (1988) Transcriptional control of high molecular weight keratin gene expression in multistage mouse skin carcinogenesis. Cancer Res. 48, 3245 3252.
30. Stoler A, Kopan R, Duvic M, Fuchs E (1988) Use of monospecific antisera and cRNA probes to localize the major changes in keratin expression during normal and abnormal epidermal differentiation. J. Cell Biol. 107, 427 446.
31. Fuchs E (1990) Epidermal differentiation: the bare essentials. J. Cell Biol. 111, 2807 2814.
32. Sade J (1972) Epithelial invasion of intraossicular spaces. J. Laryngol. Otol. 86, 15 21.
33. Seitz CS, Freiberg RA, Hinata K, Khavari PA (2000) NF-kappaB determines localization and features of cell death in epidermis. J. Clin. Invest. 105, 253 260.
34. Kaufman CK, Fuchs E (2000) It's got you covered. NF-kappaB in the epidermis. J. Cell Biol. 149, 999 1004.
35. Qin JZ, Chaturvedi V, Denning MF, Choubey D, Diaz MO, Nickoloff BJ (1999) Role of NF-kappaB in the apoptotic-resistant phenotype of keratinocytes. J. Biol. Chem. 274, 37957 37964.